Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,816,621
  • Shares Outstanding, K 44,877
  • Annual Sales, $ 1,112 M
  • Annual Income, $ 12,530 K
  • EBIT $ 17 M
  • EBITDA $ 111 M
  • 60-Month Beta 0.83
  • Price/Sales 1.55
  • Price/Cash Flow 12.56
  • Price/Book 1.41

Options Overview Details

View History
  • Implied Volatility 48.38% (-1.47%)
  • Historical Volatility 50.68%
  • IV Percentile 23%
  • IV Rank 23.63%
  • IV High 89.58% on 04/08/25
  • IV Low 35.63% on 02/10/25
  • Expected Move (DTE 15) 7.68 (19.38%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 532
  • Open Int (30-Day) 555
  • Expected Range 31.93 to 47.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.28
  • Number of Estimates 2
  • High Estimate 0.32
  • Low Estimate 0.23
  • Prior Year 0.45
  • Growth Rate Est. (year over year) -37.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.25 +19.13%
on 11/18/25
40.59 -2.41%
on 12/03/25
+5.11 (+14.81%)
since 11/04/25
3-Month
29.06 +36.30%
on 10/15/25
40.59 -2.41%
on 12/03/25
+6.49 (+19.60%)
since 09/04/25
52-Week
22.66 +74.80%
on 05/06/25
47.82 -17.17%
on 12/09/24
-6.30 (-13.72%)
since 12/04/24

Most Recent Stories

More News
3 Low-Volatility Stocks That Concern Us

3 Low-Volatility Stocks That Concern Us

OMCL : 39.61 (-2.15%)
KHC : 24.59 (-1.76%)
BANF : 110.18 (-0.93%)
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know

CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know

COO : 77.03 (+1.38%)
OMCL : 39.61 (-2.15%)
BAX : 18.48 (-2.17%)
IRTC : 181.35 (-0.92%)
NEOG : 5.93 (-0.17%)
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, announced that it will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December...

OMCL : 39.61 (-2.15%)
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

National certification demonstrates enterprise-grade oversight of specialty pharmacy enablement programs

OMCL : 39.61 (-2.15%)
3 Russell 2000 Stocks with Warning Signs

3 Russell 2000 Stocks with Warning Signs

OMCL : 39.61 (-2.15%)
AGM : 175.89 (-0.58%)
CWST : 94.71 (-1.01%)
Why Omnicell (OMCL) Stock Is Trading Up Today

Why Omnicell (OMCL) Stock Is Trading Up Today

OMCL : 39.61 (-2.15%)
Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars

Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars

OMCL : 39.61 (-2.15%)
Omnicell: Q3 Earnings Snapshot

Omnicell: Q3 Earnings Snapshot

OMCL : 39.61 (-2.15%)
Omnicell Announces Third Quarter 2025 Financial Results

Omnicell delivers strong third quarter financial results Results exceed previously issued third quarter 2025 guidance on all metrics ...

OMCL : 39.61 (-2.15%)
Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect

Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect

OMCL : 39.61 (-2.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 41.77
2nd Resistance Point 41.16
1st Resistance Point 40.39
Last Price 39.61
1st Support Level 39.01
2nd Support Level 38.40
3rd Support Level 37.63

See More

52-Week High 47.82
Last Price 39.61
Fibonacci 61.8% 38.21
Fibonacci 50% 35.24
Fibonacci 38.2% 32.27
52-Week Low 22.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar